Ausgabe 11/2022
Inhalt (17 Artikel)
Phenotypic and genetic classification of diabetes
Aaron J. Deutsch, Emma Ahlqvist, Miriam S. Udler
A novel diabetes typology: towards precision diabetology from pathogenesis to treatment
Christian Herder, Michael Roden
Achievements, prospects and challenges in precision care for monogenic insulin-deficient and insulin-resistant diabetes
Amélie Bonnefond, Robert K. Semple
Do gene–environment interactions have implications for the precision prevention of type 2 diabetes?
Thorkild I. A. Sørensen, Sophia Metz, Tuomas O. Kilpeläinen
Lifestyle interventions in pregnancy targeting GDM prevention: looking ahead to precision medicine
Joshua R. Sparks, Nidhi Ghildayal, Marie-France Hivert, Leanne M. Redman
A roadmap to achieve pharmacological precision medicine in diabetes
Jose C. Florez, Ewan R. Pearson
Pharmacoepigenetics in type 2 diabetes: is it clinically relevant?
Charlotte Ling
Precision medicine in type 1 diabetes
Alice L. J. Carr, Carmella Evans-Molina, Richard A. Oram
Precision prognostics for the development of complications in diabetes
Catarina Schiborn, Matthias B. Schulze
Coordination of glucose monitoring, self-care behaviour and mental health: achieving precision monitoring in diabetes
Norbert Hermanns, Dominic Ehrmann, Amit Shapira, Bernhard Kulzer, Andreas Schmitt, Lori Laffel
The role of mental disorders in precision medicine for diabetes: a narrative review
Sanne H. M. Kremers, Sarah H. Wild, Petra J. M. Elders, Joline W. J. Beulens, David J. T. Campbell, Frans Pouwer, Nanna Lindekilde, Maartje de Wit, Cathy Lloyd, Femke Rutters
One size does not fit all: an historian’s perspective on precision diabetes medicine
Arleen M. Tuchman
Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time
Simon Griffin